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~----'~ Genetic Polymorphlsma Renln-Anglotensln of  the 
System In Familial Dilated Cardlomyopathy 
T, Zoqal ~ , M, Vattn ~ , D, Gregorl, C, Recto, S, Mlocie ~ , M, Matultc ~ ,
M, Gtncra t , L, Mestronl ~ , International Centre for Genetic Engineering. 
Italy: t BIote(:hnology, Institute of Sf~ltlstics of the Unlversl~ Dcp,,lrtment of 
Cnrdiotog/ Hospital, 7}'testa, Italy 
In order to assaaa the role of the mn,n.nnglotensln 6yntem genes a~ ,u~cop- 
tibility factors, we tnvo#tlg~tod the a~t~oclatlon of the anglotensln.convafltno 
~n~ymo gone (ACE) the anglotanslnogen gone (AGT) and the gone for 
recaplor 1 el the anglotansln It (AT1) polymorphtsma with the Idlop,'tlhtc 
dilated e~rdlomyopathy (IDC) In n |lmuP of 41 famlltoe (20 with sporadic 
DO, 16 with autosomal dominant inl~rltance, 2 with X.tlnked OC and 3 with 
~ulo~omal dominant OC and myop~tl~y), Family t~tudle~ inchtdod clinical 
a~nmlnatlon, ECG and ocnocardlogrsphy of all available relatives, nnd full 
Inv~lve ewluatton of the p~tlonta, One hundred nnd seventeen of the In, ~tly 
members, (70 ~ffocted, 38 heallhy nnd 9 unknown) were genotypod for :he 
I/[3 polymorphlsm of ACE gone, angt,'~tanslnogen M~35T polymoq]h!~m ,nd 
Al16(~C potymot~hlsm of AT1 gone, The ACE genotype was an~tys~J by 
polymemse chain maatton wh0ma~ Ihe M235T of the AGT gone ns wall as 
A11(~6C c~f the ATI gone wore dotec=ted by Tth 111 1 digestion el the PCR 
prodoct, The frequency of the mut~te alleles and genotypos in the p~thtntn 
with DC ~nd In their relntlve~ worn enmpnmd with tl~etr frequency in a eOlttrOl 
gm~tp Oompo~ed by 100 healthy sublets and within different subgre, lps. 
The freq~lenay el M235T ~llele of the AGT gone in the hetero=ygeus and 
hemowgous form, resulted stgntflc~ttvely l~Igher In the subincta with DC m 
~ompafi~on with the oontrol gPoup (p =, 0,0004 for the presence 01 the mu, 
toted ntlele and p =~ 0.001 for the pmsonc(~ of the mutated genotype), On the 
other hand, the froquency of Al1(~6C allele 01 the AT1 gone and the result. 
tng mutated genotype were higher in the group with familial OC in respect 
of the patient~ with the sporadic term of DC (p ~ 0.0338 ,~nd p ~ 0,0492 
respectively). The data support II~a hypothe.~is that genetic variants o1 the 
genes involved ~n the renln-angiotensin system can represent susceptibility 
factors for the development of DC and in particular for the familial form el the 
disease, 
9:45 
~The Anglotenaln Converting Enzyme DD Genntype 
la Associated With a Decreased Response to 
Angloteneln II In Human Arteries 
P,P van Gaol, A,A Voom, M. Oostorgn, Y.M. Pinto, H. Buikoma, A. van 
Button, H,J,G.M, Cain.% J.H Kingmn, W.H. van Gitst. University of 
Groningen and St, Antom¢~s Hospital N~eut~%lein, The Netherlands 
Background: The delohon tvpe (DD) gano for the angiotonsm converting 
enzyme lACE) seems to be involved ~n cardiovascular disease, and has 
been associated with n higher plasma ACE-activity However, the influence 
of the ACE-genotype on functional vascular responses to angiotensin (Ang) 
II remains uncertain. 
Method~: From 137 potionts undergoing coronary bypass surgery, excess 
int~mal mammary arlones worn han/ested. Aden/nngs wore contracted to 
Ang II (0,1 aM-1 I~M) in o~an baths, end responses were expressed as the 
pomontago el the response to 10 I~M phonylephnno. 
Re.~ulfs: Patients with the DD gonotypo (n = 38) had increased plasma 
ACE-activily levels compared fo patients with the II/ID gonotypo (n = 99) 
(DD 26,9 ~: 1.2 U,,I. vs. II/ID 21.3 ± 1.0 U/L, p = 0,002), Functional vascular 
responses to Ang II were decmosod in the DD group. Maximal contraction 
in the DD group (n = 13) was 36.2 ~- 5.1% compared to 55.7 ~: 4.6% in the 
IltlD o~mt=e (n = 25) (p = 0.01). 
Conclusion: The ACE DD genotype is associated with an increased 
plasma ACE-activity and a decreased vascular response to Ang I.  These 
findings might be explained by a down regulation of AT1 rocoptom m re- 
sponse to an activated renin-angiotensin system. 
[• Coronary Stents: Radiation and Stent Grafts 
Wednesday, April 1, 1998, 8:30 a,rn.-10:00 a.m. 
Georgia World Congress Center, Lecture Hall 3 
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~ Short-term (1 Month) Reaults of the Oole Response 
IRIS FeaIlblllty_ Study of a B,Jta-Partl©la Emitting 
Radioisotope Stoat 
J,W, Manes, 8G,  Ellis, S,R, Bailey, B,O. Raybuck, P$~ Teirstein, 
N,J, Wei~m~n, J,J, Popm,,1, For the IRIS Investigafor~, Leno~ HIlt HOspital, 
New York, NY, USA 
Recent investigations ttggest that local m~diation and stent!ng may ~uce  
rOstenosis post PTCA. The expansion phase el the IsoStents for Rostenosts 
Intenmntion Study (IRIS) is designed to determine the safety el implanting 
Palmaz-Schat~ coronary stents with ~ level el radioactivity (0.75 I,Ci--.t.50 
i,Ci) above the original feasibility study (0,50 j~Ci-tO0 ~,Ci). Radioachvtty 
IS impadod by 0mbeddtng th0 pure bota.paflicle emitter, phosphorous.3P. 
(P3.~), beneath the sudaco o! the slant. Average slant activity was t ~0~ ~¢Ct 
at implnnt, 27 radioisotope slants w~re euccesstu!ly ~mplanted m de nova (n 
= P-~) or restenotic (n = 3) lesions in 25 patients (LAD = t l ,  Ctre = 7, RCA = 
7). 
QC^ mSuiis tn ~ t,t) Pm Post 
Reference vessel 2 e~ t 0 46 2 98 i 0 55 
Percent stenosls 681 t 14 ~ 00 t 15, 
Mlnlmttm Lumen Diem.tar Ot'lt 1 050 28; = t 0 31 
At 30 days, no patients had vessel closure, any MI, target vessel revas- 
culanzatton, doatl~ or noutropenia. Six month chnlcaL angtographtc, and 
inlravaseular ullrasound follow.up will be presented. 
Cone/asians: P32 radloisotopo slants can be safely tmplanted with a h~h 
immediate success rate and no unexpected adverse events at one monm. 
8:4,5 
~A/3 -emi t t ing  Liqutd Isotope Filled Balloon Markedly 
Inhibits Restenosis in Stented Porcine Coronary 
Arteries 
R. Makkar, J. Whiting, A. Li, H. Cordoro, H Honda, A. Fnmemnan, 
F. Litvack, N. Eigler. Cedars-Sinai &'radical Center. Los Angeles. CA. USA 
Background: We hypothesized that a balloon based hqutd p-emitting brachyther- 
spy would r0sult in homogeneous dose distnbution and more effectively 
inhibit slant restenosLs. 
Methods and Results: Efficacy at Re ~ td : t~ ~ = 17 hours) tdled balloon 
catheter was tested =n a 30 day porcine coronary model ot m-slant restenos~s 
in a random=zed operator blinded prOtoCol. In 7 normolipemic pigs, 20 mm 
segment of coronary artenal wail to left antenor descending or oght coronary 
artery was pretmated with a balloon catheter tilled with FIe ta~ or normal 
saline (n = 6 orleans in each group) followed by overstretch lnlury stem 
implantation. Average treatment times were 7 minutes both for saline and 
Re t~ group to deliver doses of 14 Gy at 0,5 mm tissue depth. Restenosis was 
assessed by measunng mean and max=mum percent stenosls by quantitatwe 
coronary angiography and neointimot area (IA) by intravascular ultrasound 
(IVUS). Mean exposure to the operators was below 5 mRem/treatment. Blood 
samples showed no leak of radioactive marshal 
Angtographic stenosis (%) IVUS 
Mean Maximum IA (ram 2) Area stenosl$ 
Placebo 60 -t 9 62 :t 11 3.3 ± 26 41 ± 21°'o 
Re 1~9 tO ~ 17' 32 ± 2;~ ~ 0.  ~ ± 06" 17 ± t1%" 
p - 0.01, ~ p • 0.05. Results o1 hlstomorphometPt will be presented. 
Conclusion: Treatment with Re ~"8 filled balloon peer to stenting effective;y 
inhibits (re)stenosis in porcine coronaries and is logistically feasible 
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~l~.~duct lon  of Neointimal Proliferation After 
Implantation of a Beta Particle Emitting Gold Au 198 
Coated Stent 
E. AIt, R.A. Herrmann, A. Rybnikar, J.B. Knebel, G. Ritscher. B. M~rkl, 
J. Hausleiter, I. Wolf 1 , W. Erhardt, M. Schwaigor t, A. SchSmig. I. Med. Klin~k 
and Deutsches Herzzentrum, Germany: ~ Nuklearmed. K/inik, Klinikum 
rechts der tsar, Technische Universittit ME~nchen, Germany 
Background: Restenosis following intracoronary stent placement continues 
JACC l:¢hman, 1~)*)8 351A 
to be el ¢01%-~m. Reran1 sludies have shown the bon~fic~RI effect of beta 
radiation m ~'roventmg smoolh muscle coil proliferation following ang~opla.~ty 
and stem plaeemem Radioactive gold Au 198 (h~llhfo 27 d, 096 MeV) 
might b~ useful aa a beta soumo stnce it may interaCt Io~s with endothelial 
cell ~r0wlh  duo ~o ~fs short hnlt hfn. Th~s study mvostlgat0~ the effect Of 
dtfforeof (t0ses Of Au 198 gold coated slants on neointimal prolifemhon in the 
an!n~l model 
Methods. Got¢3 coated (5 ~m) stmnless steel stents (InFlow Dynam;cs, 
Munich, C~m~ny) were ac11vale~ in the neutron I~am of a nuc le i  reactor 
Stent a~31~vffms wero prock=¢ed to tall into ~ (JOSe qategones ranging from 0 
Gravy (Gy) 1o ~0 Gy. Th~r~*-s=x stems were random;~, implanted m the Coronary 
adeees 01 t8 min~p~ Iof~avascular ultrasound (!VU,~) was Pe~0med at 4 
weeks, fl!slomoq~homeln/and repeat IVUS wd! be per to~ at t2 weeks 
Resutt~.: lmp4anfatlons of the g~l  stems were successful with no acum 
complications. C~e~tmtqh based on the !VUS =ndioaled nO s~gniticant d~t. 
fe re~ b#~n the eye,stretch on the comml and mdiwdua! (:toses~ The 
bttnded !VUS iovesl~gat~on at 4 weeks ~r',(/ioa*es a ~ose ~pendem effect On 
~=~,o(fltilTt~l prehte,at~On 
" " p<Ol l l  v.~ ¢'oalrtil 
II 
L'ontro| t).2 1|.h5 2.2 h.7 20 Gy 
Cof"~ch~on: These 4 week IVUS data md~cate a s~gnd~can! reduction of 
neomt~mal ceil grewzh t~r~j  ~p~t~n at a Au198 coateO ra~oact~e 
stent. 12 week IVUS and histo/'norphometnc resutts w~i| be reported a'~ well 
3:15 
-8 -~ Cl in ical  and  Ang iograph i¢  Fo l low-up  A f te r  
Autologous Vein Graft -coated Stent  Implantat ion  
C Stetana~s, K Toutouzas. E Ts~arn~s. C  Vlachopoufos. C. St~.t~,s. 
I Kalt~kazaros. M. VaYd'ranek~s. P Toutouzas H~pp~3kratrOn Hog.tat. 
Un~[ers*t~ of Athens. GreeCe 
Backgtour~.- In pre~'~ou~ ~tt.~e~ we have shown ta',~ora..~te rasu~ after aural- 
ogo~s vein graft-coated stent (AVGCS) ;mp{antat~on = ar~rnals (JACC 1996: 
28. 1(~,~9-1046]. Th~s Is the first report of the immediate and long-term results 
of AVGC$ fmplantat~n tn 51 patients (pts). 
P.fethods: A 3-4 cm vein graft was removed ~ the nght cephat~c vein 
A stent was either covered comp~teh/both extemaih/ar~J internally (type A) 
oc only extematty (type B) by the g~ft A Palmaz ", a Palmaz-Schatz" or a 
Mu~lmk" stent was used for the procedure The veto hmng was stab~hzed 
on the stent by sutures (Prolene 7-Oy F~by-three AVGCSs It0 ~ype A. 43 
type B) were implanted in 51 pt~ (59 : 8 yrs) tar the tallowing indications: 16 
AVGCSs in elective les~ns, 7 in astral lesions, 6 ~n totally occluded vessels. 
10 far treatment of acute ~rdta l  intarct~on (AMI). 7 =n by-pass vein grafts. 
and 7 as a bail-out ~ .  
ResuttS: The AVGCS preparation was feasible and short ~n durahon (- 20 
m~n) to~" both tyl~es. No case of thror~J~os~s was obser~ecL except o~e patient 
who presented with subacute thrombosis 20 days after the procedure. The 
minimal luminal diameter (MLD) was increased tram 0.33 ± 0.33 mm to 322 
~- 0 48 mm (n = 53. p ° 0.0OI ). Two pLs required a repeat ang~oplasty and 
2 pts underwent non-emergency coronary by-pass surgery. Neither death 
nor myocardial infarction was reported dunng the follow-up period In 21 pts 
(23 lesions), mctuding the pts wdh chnical restenos=S, an ang~ography was 
performed after 7.5 ± 2 months (MLD immediately after: 316 ± 0.39, MLD 
folloW-UD: 2.26 ~ 0.54 mm). The event-free survival ~ate at 2 years tallow-up 
was 89% ~Gr~ph). 
; . . . .  
F-allow.u0 (morM~l 
Conc/usion: The chnical expenence by using the AVGCS was encouraging 
regarding the acute and long-term results. Large randomized rnutticenter 
studies are warranted to show the clinical value of this type of stent. 
9:30 
[ _8~ Stents Coaled by an Auto logou= Arterial  Graft: The 
. . . . . . . . .  F l int  Appl icat ion In Human Coronary Artertes 
K Toutouza =-, C, Stef~na~,s, E Ts,am,s. C, Vtachopoutos. C. Strafes, 
I Katlikazaros, P. Toutouzas, Hlppokra,.~n t- lo~al,  Ur~ve~ffy at Amens, 
Gvee~. 
Background: Expenmental Stuc!nes from Our mst~tuhon here, fm(~n tavo~a¢~e 
results of the autologous artena! graft~co~ted stont (AAGCS) implanlation 
~n pomme coro~a~/ stlenes, This iS the fir~.t report el th~ Im~iate  She 
follow-up r~gffS 0f AAGC~ Implantation !n 15 palmnts [pls=), 
Methods: After gefformmQ Allen's lest a 3--4 cm grail w~ harveste<l from 
the tell radial artery and cleared from the bounOaq/tissues, A pre~nO~nted 
Muttibnk" stem was covered exlematly by the arlena! graft, wh,:h was ~-  
bd,zed on the stem I~y 3 sutures (Prolene 7,0) at each end (figure). F inn  
AAGCSs were implanted m 1,5 pls (55 ± ? ym). Nine AAGCSs were placed m 
sapheno~s veto grafts, 5 ,n elective les~ons, and I in o~itlal lesion. All pts left 
hosp~tat uncte~ aspmn ancl t~cloptdine and they were scheduled for treadmill 
Resut*.~: The procedure of stent coating was teas~bte and short in duration 
{<20 m~n~, w~'mut compftcafm~s. The min~nal uminal diameter (MID) was 
increased from 0.47 ± 0215 to 3.06 ~ 0~'~ mm (n = 15, p < 0.001). NO case 
of thremloos~$ was at, served and all pts were d, scharged wrtho~t symptoms. 
At! pts r~d negat~e TST, e~cept o~e w~h recurrence of symplorn~ afler 3 
months. In 9 pts an ang~grapr'~ was performed after 6,12 ± 1.11 months 
(MLD ~mmed~tety after: 3.09 ~ 0.51 mm, tallow-up: 2.39 ± 0%3 mm, n = 9, 
p = NS). 
Conctus~on: The preliminary results by using the AAGCS were encourag- 
=n 9 regardm 0 the feasibility and the thrombosis and restenosis rate. Large 
multfcenter studies are needed to it~cate rite clinical value at th~s new type 
of COated slant. 
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~6-~ Microfabr icated Device fo r  Del ivery Intravascular  
M FefOman. J Kneller. C Wu. ~ Walkms, L Weiss ~ , M. Reed ~ Cam~e 
Me/~on Um,~ersffg USA: ~ and Unrvetsdy of Prtt~urgh. Poffsburgh PA. USA 
Pefcutaneous c~ret~ary dnten,,entJon fs currently used to tn~t coronary ath- 
erescteresla but is plagued by restenosm. We hypcthes~ze thai a stent vv~h 
integrated r,~crofabncated probes (fig. 1 ), can produce co~rolied inc~slons 
~rcugh atherescferot~c plaque enabling me detrvery of t~gh concer~ra~ion 
drug or gone therapy. Three sets of m~crofabrcated probes (65 ± 15, 120 ± 
20. and 185 = 25 ~,ml were deployed in normal and atherosclerctic 
Eltac artery segments (n = 5 eaCh) under physroIog=c dzsten~on at pressures 
of t00, 300, and 500 mmHg to s~mulate post-stent,~J conditions. The tissues 
were fixed white the pmt~s romarne~ in ptace and analyzed us,rig SEM. 
TEM. and hum m~crescopy to evaluate the extent and nature of vessel pen- 
et~tlon Figure 2 shows how n~,3~o~;,o~ produce controlled incisions in 
the artenal wall. 
Microprobes are able to p~erce the internal elastic lamina and penetrate 
the media, with the h~ghest probes neady reaching the media/advent~ba 
boundary. Th~s data suggests that a microprobe-studded stent can achieve 
COntrolled incisions into the a."tenal wall and may facilitate the clelrvery of 
therapeutiCS beyond atherosclerotic plaque. 
